19 Feb 2021 11:10
PT Kalbe Farma Tbk (KLBF) through its subsidiary, PT Kalbe Genexine Biologics (KGBio), has signed a license agreement with Genexine amounting to US$ 1.1 billion.
Kalbe Farma signs US$ 1.1 billion Covid-19 drug license agreement with Genexine 27 Jan 2021 09:49
PT Kalbe Farma Tbk (Kalbe) through one of its subsidiaries, PT Kalbe Genexine Biologics (KGBio) announced that General Atlantic (GA), a global financial investor company from the United States will invest USD 55 million as primary capital in KGBIo.
General Atlantic invests USD 55 million in Kalbe Genexine Biologics 30 Dec 2020 10:34
PT Kalbe Farma Tbk (KLBF) has closed a subsidiary, Kalbe Global Pte, Ltd (KG), in Singapore following the closure in Philippines.
Kalbe has closed its subsidiary in Singapore 23 Dec 2020 18:19
Towards the end of 2020, with a healthy financial position, PT Kalbe Farma Tbk (KLBF) has distributed an interim dividend of Rp 281.3 billion to shareholders on 18 December 2020.
Kalbe Farma distributes interim dividend of Rp 281.3 billion 02 Nov 2020 10:58
PT Kalbe Farma Tbk (KLBF) inaugurated the 7th KALCare outlet at AEON Sentul City which is on the 1st floor and is the first KALCare outlet in Bogor.
Kalbe opens the seventh KALCare outlet 02 Oct 2020 05:29
PT Kalbe Farma Tbk (KLBF) has transferred all of its shares in PT Kalbe Morinaga Indonesia (KMI) and PT Kalbe Milko Indonesia (KAMI) to PT Sanghiang Perkasa, its subsidiary and the nutrition division of Kalbe Group.
Kalbe Farma transfers all of its shares in KMI and KAMI to its subsidiary 14 Sep 2020 15:48
PT Kalbe Farma Tbk (KLBF) established a new subsidiary, PT Kalbe Biotek Indonesia with an authorized capital of Rp 50 million, even though its debt rose by 37.96% in the first half of 2020.
Kalbe Farma establishes a new subsidiary 01 Sep 2020 14:42
PT Kalbe Farma Tbk (KLBF) estimates that the investment required to produce the COVID-19 vaccine will reach Rp 500 billion-Rp 1 trillion for 50 million doses
Kalbe Farma estimates that the investment required for COVID-19 vaccines to reach Rp 1 trillion 01 Sep 2020 13:39
PT Kalbe Farma Tbk (Kalbe) in collaboration with doctorSHARE provided Personal Protective Equipment (PPE) in the form of 4,200 Surgical Masks, 520 Hazmat Suit Medical Grade and 150 Hazmat Non Medical Grade through the Indonesia Global Compact Network (IGCN)
Kalbe Farma donates PPE for floating hospitals 27 Aug 2020 10:25
PT Kalbe Farma Tbk (KLBF) posted a sales increase of 3.8% to Rp 11.60 trillion in the first semester (1H) of 2020 from Rp 11.17 trillion in the same period last year.
Kalbe Farma posts Rp 11.60 million in sales in 1H